Annual FCF
-$8.45 M
+$924.80 K+9.87%
31 December 2023
Summary:
Hoth Therapeutics annual free cash flow is currently -$8.45 million, with the most recent change of +$924.80 thousand (+9.87%) on 31 December 2023. During the last 3 years, it has fallen by -$2.15 million (-34.07%). HOTH annual FCF is now -301.75% below its all-time high of -$2.10 million, reached on 31 December 2018.HOTH Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$1.63 M
-$42.90 K-2.70%
30 September 2024
Summary:
Hoth Therapeutics quarterly free cash flow is currently -$1.63 million, with the most recent change of -$42.90 thousand (-2.70%) on 30 September 2024. Over the past year, it has increased by +$2000.00 (+0.12%). HOTH quarterly FCF is now -363.45% below its all-time high of -$352.70 thousand, reached on 31 March 2018.HOTH Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$8.02 M
+$2000.00+0.02%
30 September 2024
Summary:
Hoth Therapeutics TTM free cash flow is currently -$8.02 million, with the most recent change of +$2000.00 (+0.02%) on 30 September 2024. Over the past year, it has dropped by -$88.40 thousand (-1.11%). HOTH TTM FCF is now -2174.37% below its all-time high of -$352.70 thousand, reached on 31 March 2018.HOTH TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HOTH Free Cash Flow Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +9.9% | +0.1% | -1.1% |
3 y3 years | -34.1% | +41.5% | +10.9% |
5 y5 years | -301.8% | +3.2% | -101.9% |
HOTH Free Cash Flow High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -34.1% | +30.8% | -12.8% | +58.3% | -1.8% | +34.3% |
5 y | 5 years | -301.8% | +30.8% | -127.9% | +58.3% | -101.9% | +34.3% |
alltime | all time | -301.8% | +30.8% | -363.4% | +58.3% | -2174.4% | +34.3% |
Hoth Therapeutics Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$1.63 M(+2.7%) | -$8.02 M(-0.0%) |
June 2024 | - | -$1.59 M(-7.7%) | -$8.02 M(+1.8%) |
Mar 2024 | - | -$1.72 M(-43.9%) | -$7.88 M(-6.7%) |
Dec 2023 | -$8.45 M(-9.9%) | -$3.07 M(+87.7%) | -$8.45 M(+6.5%) |
Sept 2023 | - | -$1.64 M(+12.9%) | -$7.93 M(-8.6%) |
June 2023 | - | -$1.45 M(-36.7%) | -$8.68 M(-8.7%) |
Mar 2023 | - | -$2.29 M(-10.5%) | -$9.50 M(+1.4%) |
Dec 2022 | -$9.37 M(-23.2%) | -$2.56 M(+7.5%) | -$9.37 M(-12.7%) |
Sept 2022 | - | -$2.38 M(+4.6%) | -$10.73 M(-3.7%) |
June 2022 | - | -$2.27 M(+5.2%) | -$11.15 M(-3.7%) |
Mar 2022 | - | -$2.16 M(-44.9%) | -$11.58 M(-5.2%) |
Dec 2021 | -$12.21 M | -$3.92 M(+40.3%) | -$12.21 M(+35.6%) |
Sept 2021 | - | -$2.79 M(+3.5%) | -$9.00 M(+16.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2021 | - | -$2.70 M(-3.3%) | -$7.74 M(+3.6%) |
Mar 2021 | - | -$2.79 M(+289.3%) | -$7.47 M(+18.6%) |
Dec 2020 | -$6.30 M(+25.0%) | -$717.20 K(-53.0%) | -$6.30 M(-11.4%) |
Sept 2020 | - | -$1.53 M(-37.3%) | -$7.11 M(-2.2%) |
June 2020 | - | -$2.44 M(+50.1%) | -$7.27 M(+23.4%) |
Mar 2020 | - | -$1.62 M(+6.5%) | -$5.89 M(+16.8%) |
Dec 2019 | -$5.04 M(+139.8%) | -$1.52 M(-9.7%) | -$5.04 M(+26.9%) |
Sept 2019 | - | -$1.69 M(+59.8%) | -$3.97 M(+33.2%) |
June 2019 | - | -$1.06 M(+36.5%) | -$2.98 M(+18.2%) |
Mar 2019 | - | -$774.00 K(+70.1%) | -$2.52 M(+20.0%) |
Dec 2018 | -$2.10 M | -$455.10 K(-34.8%) | -$2.10 M(+27.6%) |
Sept 2018 | - | -$697.60 K(+16.8%) | -$1.65 M(+73.4%) |
June 2018 | - | -$597.20 K(+69.3%) | -$949.90 K(+169.3%) |
Mar 2018 | - | -$352.70 K | -$352.70 K |
FAQ
- What is Hoth Therapeutics annual free cash flow?
- What is the all time high annual FCF for Hoth Therapeutics?
- What is Hoth Therapeutics annual FCF year-on-year change?
- What is Hoth Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Hoth Therapeutics?
- What is Hoth Therapeutics quarterly FCF year-on-year change?
- What is Hoth Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Hoth Therapeutics?
- What is Hoth Therapeutics TTM FCF year-on-year change?
What is Hoth Therapeutics annual free cash flow?
The current annual FCF of HOTH is -$8.45 M
What is the all time high annual FCF for Hoth Therapeutics?
Hoth Therapeutics all-time high annual free cash flow is -$2.10 M
What is Hoth Therapeutics annual FCF year-on-year change?
Over the past year, HOTH annual free cash flow has changed by +$924.80 K (+9.87%)
What is Hoth Therapeutics quarterly free cash flow?
The current quarterly FCF of HOTH is -$1.63 M
What is the all time high quarterly FCF for Hoth Therapeutics?
Hoth Therapeutics all-time high quarterly free cash flow is -$352.70 K
What is Hoth Therapeutics quarterly FCF year-on-year change?
Over the past year, HOTH quarterly free cash flow has changed by +$2000.00 (+0.12%)
What is Hoth Therapeutics TTM free cash flow?
The current TTM FCF of HOTH is -$8.02 M
What is the all time high TTM FCF for Hoth Therapeutics?
Hoth Therapeutics all-time high TTM free cash flow is -$352.70 K
What is Hoth Therapeutics TTM FCF year-on-year change?
Over the past year, HOTH TTM free cash flow has changed by -$88.40 K (-1.11%)